Homepage
Medication Guide
Dosage and Administration of Volanesorsen (Waylivra)
Volanesorsen (Waylivra) is an antisense oligonucleotide drug that selectively inhibits apolipoprotein C-III (apoC-III). It is specifically indicated for adult patients with genetically confirmed famil...
511
Thursday, November 27th, 2025, 13:04
What are the Indications for Volanesorsen (Waylivra)?
Volanesorsen (Waylivra) is a medication indicated for the treatment of specific hereditary hypertriglyceridemia. By inhibiting the synthesis of apolipoprotein C-III, it effectively reduces blood trigl...
510
Thursday, November 27th, 2025, 11:59
What are the Purchase Channels for Volanesorsen (Waylivra)?
Volanesorsen (Waylivra) is a prescription medication indicated for the treatment of familial chylomicronemia syndrome (FCS) in adult patients, particularly those who have not responded adequately to d...
507
Thursday, November 27th, 2025, 11:35
Side Effects of Gefapixant Tablets (Lifnua)
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist indicated for the treatment of refractory chronic cough.Side Effects of Gefapixant Tablets (Lifnua)Taste-Related Side EffectsTaste d...
508
Thursday, November 27th, 2025, 11:32
What are the Administration Precautions for Gefapixant Tablets (Lifnua)?
Gefapixant Tablets (Lifnua) is an innovative selective P2X3 receptor antagonist specifically indicated for the treatment of refractory chronic cough. With the increasing clinical application of this m...
508
Thursday, November 27th, 2025, 11:03
Dosage and Administration of Gefapixant Tablets (Lifnua)
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist specifically indicated for symptomatic treatment in patients with refractory chronic cough.Dosage and Administration of Gefapixant T...
505
Thursday, November 27th, 2025, 10:53
What are the Indications for Gefapixant Tablets (Lifnua)?
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist classified as a cough treatment medication. Launched in Japan in April 2022, it is primarily indicated for the treatment of refracto...
506
Thursday, November 27th, 2025, 10:49
What are the Purchase Channels for Gefapixant Tablets (Lifnua)?
Gefapixant Tablets (Lifnua) is a selective P2X3 receptor antagonist indicated for the treatment of refractory chronic cough. It has been marketed in Japan since April 2022. As a prescription drug, its...
507
Thursday, November 27th, 2025, 10:44
How to Use Sabril (Vigabatrin)
Sabril (vigabatrin) is an antiepileptic drug used to treat specific types of seizures, with vigabatrin as its main active ingredient.How to Use Sabril (Vigabatrin)Administration Route and Dosage Forms...
505
Thursday, November 27th, 2025, 10:40
Precautions for Inotuzumab ozogamicin (Besponsa) Administration
Inotuzumab ozogamicin (Besponsa) is a key therapeutic agent for relapsed or refractory CD22-positive B-cell precursor acute lymphoblastic leukemia, exerting its therapeutic effect through precise targ...
506
Thursday, November 27th, 2025, 10:36
42 / 207
2063 in total
Departments
Oncology Hematology Immunology Hepatology Endocrinology Pulmonology Neurology Cardiology Gastroenterology Dermatology
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
haiousales@gmail.com
Welcome To Consult
Seagull Pharmacy.,Ltd All rights reserved